High Throughput Screening (HTS) Market is estimated to be US$ 45.30 billion by 2030

Nehashaikh27 Apr, 2022News

Global High Throughput Screening (HTS) Market accounted for US$ 15.23 billion in 2020 and is estimated to be US$ 45.30 billion by 2030 and is anticipated to register a CAGR of 11.5%. HTS is a drug discovery technique that involves screening and evaluating a large number of biological modulators and effectors against a specific target. It is commonly utilised in toxicity investigations and stem cell research. It's used to analyse chemicals in the environment, medications, and formulations for in-depth toxicological review and the establishment of disease-associated and predictive toxicological pathways. Miniaturization can help uncover harmful substances early in the medication development process, saving a lot of money. High throughput screening has achieved widespread acceptance and has become a typical method of drug discovery in the pharmaceutical industry over the last two decades. In the long run, expanded use of the HTS approach in the field of toxicity will prove advantageous.